Is CoronaVac the first Covid-19 vaccine for Malaysian children aged 5-11?

Question

Accepted Answer

CoronaVac is Not the First Covid-19 Vaccine Approved for Children Aged Five to 11 in Malaysia

The CoronaVac vaccine is not the first Covid-19 vaccine to receive approval for use in children aged five to 11 in Malaysia. The Comirnaty vaccine, produced by Pfizer, was approved for this age group earlier.
Comirnaty Approval Preceded CoronaVac

The Comirnaty vaccine was granted conditional registration approval for children aged five to 11 on January 6. This preceded the approval of the CoronaVac vaccine for the same age demographic.
CoronaVac Approval for Younger Children Announced

The conditional registration approval for the CoronaVac Suspension for Injection Covid-19 Vaccine (Vero Cell), Inactivated, produced by Sinovac Life Sciences Co Ltd and Pharmaniaga Lifescience Sdn Bhd, for children aged five to 11 was announced on March 3. This approval was agreed upon by the Drug Control Authority in its 370th meeting.
CoronaVac Previously Approved for Older Age Groups

Prior to its approval for younger children, CoronaVac had already received conditional approval for individuals aged 12 and above. The Health Ministry continues to monitor and evaluate vaccine data to ensure a positive benefit-risk balance.

Reading history

Hide →

This history is cleared when the page is closed.

Is CoronaVac the first Covid-19 vaccine for Malaysian children aged 5-11?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

3

0

0

Share with friends